-
WGS/RNA-seq pair of an inflammatory hepatocellular adenoma (IHCA)
Study
EGAS00001003025
-
Analysis of IDHwt-glioblastoma samples from paired primary and recurrent tumor samples
Study
EGAS00001003184
-
Structure and evolution of double minutes in diagnosis and relapse brain tumors
Study
EGAS00001003212
-
Whole Exome Sequencing in Multiple Myeloma
Study
EGAS00001003227
-
Adeno-associated virus in the liver: natural history and consequences in tumor development
Study
EGAS00001003310
-
Genomics of enteropathy associated T cell lymphoma (EATL)
Study
EGAS00001001954
-
Uveal melanoma patient with germline MBD4 nonsense mutation
Study
EGAS00001003362
-
THE GENOMIC LANDSCAPE OF ACTINIC KERATOSIS
Study
EGAS00001004243
-
Probabilistic cell type assignment of single-cell transcriptomic data reveals spatiotemporal microenvironment dynamics in human cancers
Study
EGAS00001003452
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Colorectal_LCM
Study
EGAS00001003455
-
Validation of a targeted sequencing panel for multiple myeloma
Study
EGAS00001006164
-
Cancer-Associated Mutations in Endometriosis without Cancer
Study
EGAS00001003576
-
Comprehensive investigation of genome architecture of gastric adenocarcinoma with whole-genome sequencing in the Chinese population.
Study
EGAS00001002404
-
BLUEPRINT DNA Methylation 450K data of mantle cell lymphoma
Study
EGAS00001001637
-
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Study
EGAS00001001653
-
Spatial and Temporal Homogeneity of Driver Mutations in Diffuse Intrinsic Pointine Glioma
Study
EGAS00001001654
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
33 patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) had whole exome sequencing performed. Cells were sorted by FACSAria using CD138, CD19 and CD56 to obtain a pure abnormal plasma cell population. Generated somatic variants were compared to a previous study of 463 multiple myeloma patients.
Study
EGAS00001001658
-
Single-cell atlas of multiple myeloma and precursor diseases
Study
EGAS00001006694
-
BCR-ABL is enriched in S- and G2-cell cycle phases
Study
EGAS00001006769
-
Mutational landscape of renal cell carcinoma with venous tumor thrombus
Study
EGAS00001001950
-
Exome sequencing of pseudomyxoma peritonei
Study
EGAS00001002418
-
Exome sequence data for germline, primary tumor, and relapse tumor of a transformed non-Hodgkins lymphoma patient with unexpected long-time remission
Study
EGAS00001001973
-
Prognostic relevance of microenvironmental factors CD163 and CD8 combined with EZH2 and chromosome 18 gain in a validation cohort of follicular lymphoma patients of the Lunenburg Lymphoma Biomarker Consortium
Study
EGAS00001002049
-
Spatial genomic heterogeneity in multiple myeloma revealed by multi- region sequencing
Study
EGAS00001002111
-
RNA-sequencing of six Pilocytic astrocytoma tumors
Study
EGAS00001002149
-
miR-200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
Study
EGAS00001002184
-
Single-cell profiling maps the spectrum of crosstalk between glioma cells and tumor associated macrophages
Study
EGAS00001002185
-
Gene fusion and transcriptomic landscapes of sarcomas
Study
EGAS00001002189
-
An Unusual Genomic Variant of Pancreatic Ductal Adenocarcinoma with an Indolent Clinical Course
Study
EGAS00001002192
-
Whole genome sequencing identified biomarker of response to PD1 blockade in Natural-killer/T-cell lymphoma
Study
EGAS00001002420
-
Defective homologous recombination in HCC
Study
EGAS00001006599
-
Sequencing of paediatric High Grade Gliomas and DIPG
Study
EGAS00001002314
-
Whole exome sequencing of an invasive diffuse intrinsic pontine glioma sampled from different sites
Study
EGAS00001002326
-
A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus.
Study
EGAS00001002334
-
Poly(A) RNA sequencing of hepatocellular carcinoma tumors and their matched noncancerous liver tissues
Study
EGAS00001002337
-
whole genome sequence data of multifocal hepatocellular carcinoma
Study
EGAS00001002338
-
Cisplatin increases sensitivity to FGFR inhibition in patient-derived xenograft models of lung squamous cell carcinoma
Study
EGAS00001002423
-
Deep single-cell RNA sequencing data for 12346 T cells from tumour, adjacent normal tissue and peripheral blood of treatment-naive NSCLC patients
Study
EGAS00001002430
-
The evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion
Study
EGAS00001002432
-
Genomic landscape of Chordoid Glioma
Study
EGAS00001002433
-
Genomic Heterogeneity and the Small Renal Mass
Study
EGAS00001002919
-
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
Study
EGAS00001002443
-
A combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancer
Study
EGAS00001002444
-
Control samples, breast cancer clinical samples and matched patient-derived tumour xenografts (PDTXs) to develop and test a computational approach to discriminate human and mouse sequences in PDTXs
Study
EGAS00001002445
-
ATRX mutant neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal differentiation.
Study
EGAS00001002507
-
Cell motility and migration as determinants of stem cell efficacy
Study
EGAS00001002478
-
Transcriptome sequencing of intravenous leiomyomatosis and uterine myoma
Study
EGAS00001002504
-
Mutational signatures of aflatoxin
Study
EGAS00001002490
-
Fibroblast heterogeneity and immunosuppressive environment in Human breast cancer
Study
EGAS00001002508
-
Sampling of multi-centric lower grade glioma influences management and provides insight into gliomagenesis
Study
EGAS00001002495
-
Genome-wide expression profiles to compare array-based, RNAseq and NanoString technologies in patients with resected pancreatic ductal carcinoma.
Study
EGAS00001002501
-
Genome-wide genetic and epigenetic dataset of pancreatic acinar cell carcinomas
Study
EGAS00001002533
-
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Study
EGAS00001002538
-
Comprehensive genetic analysis of uveal melanoma heterogeneity during metastatic progression
Study
EGAS00001002761
-
Exome-wide somatic mutation characterization of small bowel adenocarcinoma
Study
EGAS00001002559
-
Exome sequencing data from two myelosarcomas
Study
EGAS00001002562
-
Pilot study for Illumina TST170 NGS panel on cutaneous T cell lymphoma samples
Study
EGAS00001002567
-
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Study
EGAS00001002606
-
The genomic landscape of cutaneous squamous cell carcinoma from immunosuppressed and immunocompetent patients reveals common drivers and a novel mutational signature associated with chronic azathioprine exposure
Study
EGAS00001002612
-
Whole-exome sequencing of ovarian clear cell carcinoma in clinical outliers
Study
EGAS00001004248
-
HDAC inhibitors in synovial sarcoma cells
Study
EGAS00001002637
-
We performed whole-exome sequencing of 20 samples (10 actinic keratosis and 10 cutaneous squamous cell carcinoma) to investigate a potential relationship between DNA methylation-based subtypes and genetic mutation patterns (Rodriguez-Paredes et al., Nat Commun 2017)
Study
EGAS00001002670
-
Alternative splicing isoforms in patient-derived hepatocellular carcinoma cells
Study
EGAS00001002697
-
Gut microbiome modulates response to anti PD1 immunotherapy in metastatic melanoma patients
Study
EGAS00001002698
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705
-
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.
Study
EGAS00001002707
-
Aggressive genomic features in clinicallyindolent primary HHV8-negative effusion-based lymphoma
Study
EGAS00001002743
-
Defective T-cell expansion in RASGRP1 deficiency
Study
EGAS00001002753
-
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
Study
EGAS00001002757
-
Colorectal adenomas and carcinomas NKI-AvL TGO series Gut2009
Study
EGAS00001002758
-
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T-cell lymphomas with hemophagocytic lymphohistiocytic syndrome
Study
EGAS00001002765
-
Mutational spectrum of highly differentiated, fusion-negative rhabdomyosarcoma (set 2).
Study
EGAS00001002771
-
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
Study
EGAS00001002786
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
TRACERx Renal 100
Study
EGAS00001002793
-
Somatic IL4R Hotspot Mutations in Primary Mediastinal Large B-cell lymphoma lead to constitutive JAK-STAT activation
Study
EGAS00001002796
-
Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma
Study
EGAS00001002812
-
Molecular subtypes of malignant peritoneal mesothelioma
Study
EGAS00001002820
-
Whole exome sequencing of longitudinal samples from a melanoma patient receiving MEK plus CDK4/6 inhibitor therapy.
Study
EGAS00001002846
-
Targeted panel data for newly diagnosed myeloma patients.
Study
EGAS00001002859
-
Whole-genome and transcriptome sequencing of tumor-stage mycosis fungoides
Study
EGAS00001002860
-
Identification of recurrent mutations in Cushing’s disease
Study
EGAS00001003029
-
Targeted exome sequencing of pleomorphic invasive lobular carcinoma (PILC).
Study
EGAS00001002871
-
Foundation Medicine Genomic Data Used to Identify Prognostic Markers and Fusion Genes in Multiple Myeloma
Study
EGAS00001002874
-
SS18-SSX-mediated hijacking of BAF complexes drives synovial sarcoma
Study
EGAS00001002920
-
Leeds Melanoma Cohort (LMC) gene expression study
Study
EGAS00001002922
-
Colorectal advanced adenomas NKI-AvL TGO COCOS series
Study
EGAS00001002952
-
Colorectal adenomas, NKI-AvL TGO series Stool-Proteomics
Study
EGAS00001002953
-
Single cell exome sequencing of lung adenocarcinoma
Study
EGAS00001002972
-
RNAseq of Follicular Lymphoma
Study
EGAS00001002980
-
Host whole genome variations are associated with neurocognitive outcome in survivors of pediatric medulloblastoma
Study
EGAS00001002996
-
Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Study
EGAS00001002998
-
Genomic profiling of paediatric glioma cell lines
Study
EGAS00001003006
-
Biallelic tumor suppressor loss and DNA repair defects in de novo small cell prostate cancer
Study
EGAS00001003007
-
Patient-derived neuroblastoma model system OHC-NB1
Study
EGAS00001003031
-
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Study
EGAS00001003178
-
The evolutionary history of human colitis-associated colorectal cancer
Study
EGAS00001003028
-
Capture Hi-C on Hodgkin lymphoma cell line L-428
Study
EGAS00001003032
-
Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations
Study
EGAS00001003040